Alerts will be sent to your verified email
Verify Email
REMUS
|
Remus Pharmaceutical
|
The Yamuna Syndicate
|
Uniphos Enterprises
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
38.78 % | 8.83 % | 1.42 % |
|
5yr average Equity Multiplier
|
2.69 | 1.0 | 1.02 |
|
5yr Average Asset Turnover Ratio
|
1.34 | 0.06 | 0.0 |
|
5yr Avg Net Profit Margin
|
12.12 % | 152.07 % | 3799.56 % |
|
Price to Book
|
0.0 | 0.87 | 0.41 |
|
P/E
|
50.13 | 8.46 | 872.17 |
|
5yr Avg Cash Conversion Cycle
|
62.15 Days | 48.88 Days | -4.45 Days |
|
Inventory Days
|
29.3 Days | 30.86 Days | 33.27 Days |
|
Days Receivable
|
196.63 Days | 17.41 Days | 3.49 Days |
|
Days Payable
|
131.74 Days | 4.24 Days | 110.5 Days |
|
5yr Average Interest Coverage Ratio
|
52.6 | 1841.65 | 0.53 |
|
5yr Avg ROCE
|
46.86 % | 0.55 % | 1.4 % |
|
5yr Avg Operating Profit Margin
|
14.35 % | 2.8 % | -425.44 % |
|
5 yr average Debt to Equity
|
0.17 | 0.0 | 0.0 |
|
5yr CAGR Net Profit
|
83.69 % | 12.54 % | 13.98 % |
|
5yr Average Return on Assets
|
16.02 % | 8.8 % | 1.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.85 % | 74.87 % | 73.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.24 % | 0.0 | 0.01 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Remus Pharmaceutical
|
The Yamuna Syndicate
|
Uniphos Enterprises
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|